Related Experiment Video
Updated: Jun 17, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Low von Willebrand factor: sometimes a risk factor and sometimes a disease
1Departments of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. esadler@wustl.edu
Low von Willebrand factor (VWF) levels increase bleeding risk, particularly when very low. Understanding this relationship requires considering VWF alongside other bleeding risk factors, similar to cardiovascular disease management.
Area of Science:
- Hematology
- Genetics
- Epidemiology
Background:
- Low von Willebrand factor (VWF) is a hallmark of von Willebrand disease (VWD) type 1, indicating a partial quantitative deficiency.
- While VWF's role in bleeding is known, the precise correlation between VWF levels and bleeding likelihood is not fully elucidated.
- Population-wide VWF levels exhibit considerable variation, making arbitrary distinctions between 'normal' and 'low' challenging.
Purpose of the Study:
- To investigate the complex relationship between von Willebrand factor (VWF) levels and the propensity for bleeding.
- To explore the challenges in attributing bleeding events solely to low VWF, given population variability and multifactorial causes of mild bleeding symptoms.
- To propose an epidemiological approach for assessing VWF and other bleeding risk factors.
Main Methods:
- Review of existing literature on VWF pathophysiology and bleeding risk.
- Analysis of population-based data to understand VWF level distribution.
- Conceptual framework development for an epidemiological risk factor assessment model.
Main Results:
- Bleeding risk escalates as VWF levels decline, with a more pronounced effect at very low concentrations.
- Mild bleeding symptoms are frequently observed in the general population and stem from diverse causes, complicating single-factor attribution.
- The arbitrary nature of 'normal' VWF thresholds hinders clear-cut diagnosis and risk assessment.
Conclusions:
- An epidemiological strategy, integrating VWF with other risk factors, is proposed to better manage bleeding risks.
- This approach mirrors established methods for managing cardiovascular disease and venous thromboembolism risk factors.
- Further research is needed to validate this multifactorial risk assessment model for VWF-related bleeding.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Venous Thrombosis I: Introduction
Regulation of Angiogenesis and Blood Supply
Varicose Veins I: Introduction

